Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications (original articles or review articles) published in 2014 from OUS - National Advisory Unit on Late Effects after Cancer Treatment

34 publications found

Blaker YN, Eide MB, Liestøl K, Lauritzsen GF, Kolstad A, Fosså A, Smeland EB, Holte H (2014)
High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era
Leuk Lymphoma, 55 (10), 2319-27
DOI 10.3109/10428194.2013.871632, PubMed 24432894

Christiansen JR, Hamre H, Massey R, Dalen H, Beitnes JO, Fosså SD, Kiserud CE, Aakhus S (2014)
Left ventricular function in long-term survivors of childhood lymphoma
Am J Cardiol, 114 (3), 483-90
DOI 10.1016/j.amjcard.2014.04.055, PubMed 24948492

Dahl S, Loge JH, Berge V, Dahl AA, Cvancarova M, Fosså SD (2014)
Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery
J Cancer Surviv, 9 (2), 172-9
DOI 10.1007/s11764-014-0399-6, PubMed 25216609

Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Fraumeni JF, Aleman BM, Morton LM, Gilbert ES (2014)
Pancreatic cancer risk after treatment of Hodgkin lymphoma
Ann Oncol, 25 (10), 2073-2079
DOI 10.1093/annonc/mdu287, PubMed 25185241

Dybvik E, Furnes O, Fosså SD, Trovik C, Lie SA (2014)
Pelvic irradiation does not increase the risk of hip replacement in patients with gynecological cancer. A cohort study based on 8,507 patients
Acta Orthop, 85 (6), 652-6
DOI 10.3109/17453674.2014.963784, PubMed 25238432

Fitzpatrick JM, Bellmunt J, Fizazi K, Heidenreich A, Sternberg CN, Tombal B, Alcaraz A, Bahl A, Bracarda S, Di Lorenzo G, Efstathiou E, Finn SP, Fosså S, Gillessen S, Kellokumpu-Lehtinen PL, Lecouvet FE, Oudard S, de Reijke TM, Robson CN, De Santis M, Seruga B, de Wit R (2014)
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel
Eur J Cancer, 50 (9), 1617-27
DOI 10.1016/j.ejca.2014.03.010, PubMed 24703899

Fosså SD, Hess SL, Paus E, Borgen E (2014)
Circulating tumor cells in patients with metastatic castration resistant prostate cancer: exploratory findings at a tertiary referral hospital
Res Rep Urol, 6, 121-6
DOI 10.2147/RRU.S68477, PubMed 25328865

Fredriksen M, Dahl AA, Martinsen EW, Klungsoyr O, Faraone SV, Peleikis DE (2014)
Childhood and persistent ADHD symptoms associated with educational failure and long-term occupational disability in adult ADHD
Atten Defic Hyperact Disord, 6 (2), 87-99
DOI 10.1007/s12402-014-0126-1, PubMed 24497125

Fredriksen M, Dahl AA, Martinsen EW, Klungsøyr O, Haavik J, Peleikis DE (2014)
Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity
Eur Neuropsychopharmacol, 24 (12), 1873-84
DOI 10.1016/j.euroneuro.2014.09.013, PubMed 25453480

Hasenclever D, Kurch L, Mauz-Körholz C, Elsner A, Georgi T, Wallace H, Landman-Parker J, Moryl-Bujakowska A, Cepelová M, Karlén J, Álvarez Fernández-Teijeiro A, Attarbaschi A, Fosså A, Pears J, Hraskova A, Bergsträsser E, Beishuizen A, Uyttebroeck A, Schomerus E, Sabri O, Körholz D, Kluge R (2014)
qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma
Eur J Nucl Med Mol Imaging, 41 (7), 1301-8
DOI 10.1007/s00259-014-2715-9, PubMed 24604592

Hauglann B, Benth JS, Fosså SD, Tveit KM, Dahl AA (2014)
A controlled cohort study of long-term income in colorectal cancer patients
Support Care Cancer, 22 (10), 2821-30
DOI 10.1007/s00520-014-2258-4, PubMed 24821364

Hauptmann M, Fossa SD, Stovall M, van Leeuwen FE, Johannesen TB, Rajaraman P, Gilbert ES, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW et al. (2014)
Increased stomach cancer risk following radiotherapy for testicular cancer
Br J Cancer, 112 (1), 44-51
DOI 10.1038/bjc.2014.552, PubMed 25349972

Heidenreich A, Bracarda S, Mason M, Ozen H, Sengelov L, Van Oort I, Papandreou C, Fossa S, Hitier S, Climent MA, European investigators (2014)
Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programme
Eur J Cancer, 50 (6), 1090-9
DOI 10.1016/j.ejca.2014.01.006, PubMed 24485664

Holm HV, Fosså SD, Hedlund H, Schultz A, Dahl AA (2014)
How should continence and incontinence after radical prostatectomy be evaluated? A prospective study of patient ratings and changes with time
J Urol, 192 (4), 1155-61
DOI 10.1016/j.juro.2014.03.113, PubMed 24727062

Holm HV, Fosså SD, Hedlund H, Schultz A, Dahl AA (2014)
Severe postprostatectomy incontinence: Is there an association between preoperative urodynamic findings and outcome of incontinence surgery?
Scand J Urol, 49 (3), 250-9
DOI 10.3109/21681805.2014.980845, PubMed 25428752

Janberidze E, Hjermstad MJ, Haugen DF, Sigurdardottir KR, Løhre ET, Lie HC, Loge JH, Kaasa S, Knudsen AK, EURO IMPACT (2014)
How are patient populations characterized in studies investigating depression in advanced cancer? Results from a systematic literature review
J Pain Symptom Manage, 48 (4), 678-98
DOI 10.1016/j.jpainsymman.2013.11.013, PubMed 24681108

Jeppesen E, Bjelland I, Fosså SD, Loge JH, Sørebø O, Dahl AA (2014)
Does a parental history of cancer moderate the associations between impaired health status in parents and psychosocial problems in teenagers: a HUNT study
Cancer Med, 3 (4), 919-26
DOI 10.1002/cam4.245, PubMed 24723456

Johansen S, Fosså K, Nesvold IL, Malinen E, Fosså SD (2014)
Arm and shoulder morbidity following surgery and radiotherapy for breast cancer
Acta Oncol, 53 (4), 521-9
DOI 10.3109/0284186X.2014.880512, PubMed 24495044

Kiserud CE, Dahl AA, Loge JH, Fosså SD (2014)
Cancer survivorship in adults
Recent Results Cancer Res, 197, 103-20
DOI 10.1007/978-3-642-40187-9_8, PubMed 24305772

Kiserud CE, Seland M, Holte H, Fosså A, Fosså SD, Bollerslev J, Bjøro T, Loge JH (2014)
Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism
Acta Oncol, 54 (1), 49-59
DOI 10.3109/0284186X.2014.948057, PubMed 25140862

Lie HC, Hjermstad MJ, Fayers P, Finset A, Kaasa S, Loge JH, European Palliative Care Research Collaborative (EPCRC) (2014)
Depression in advanced cancer--assessment challenges and associations with disease load
J Affect Disord, 173, 176-84
DOI 10.1016/j.jad.2014.11.006, PubMed 25462414

Lilleby W, Stensvold A, Dahl AA (2014)
Adding intensity-modulated radiotherapy to the pelvis does not worsen the adverse effect profiles compared to limited field radiotherapy in men with prostate cancer at 12-month follow-up
Acta Oncol, 53 (10), 1380-9
DOI 10.3109/0284186X.2014.916042, PubMed 24844918

Nilsson R, Omland H, Dahl AA, Johansen TE (2014)
Early outcome of orchiopexy and analysis of predictive factors: a retrospective study from 2001 to 2010 in a Norwegian regional hospital
Scand J Urol, 48 (5), 474-81
DOI 10.3109/21681805.2014.905631, PubMed 24720831

Nome R, Hernes E, Bogsrud TV, Bjøro T, Fosså SD (2014)
Changes in prostate-specific antigen, markers of bone metabolism and bone scans after treatment with radium-223
Scand J Urol, 49 (3), 211-7
DOI 10.3109/21681805.2014.982169, PubMed 25515952

Oldenburg J, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, de Wit R, Fosså SD, Germà-Lluch JR, Gillessen S, Haugnes HS, Honecker F, Horwich A, Lorch A, Ondruš D, Rosti G, Stephenson AJ, Tandstad T (2014)
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
Ann Oncol, 26 (5), 833-838
DOI 10.1093/annonc/mdu514, PubMed 25378299

Pulczynski EJ, Kuittinen O, Erlanson M, Hagberg H, Fosså A, Eriksson M, Nordstrøm M, Østenstad B, Fluge Ø, Leppä S, Fiirgaard B, Bersvendsen H, Fagerli UM (2014)
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group
Haematologica, 100 (4), 534-40
DOI 10.3324/haematol.2014.108472, PubMed 25480497

Sartor O, Coleman R, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Vogelzang NJ, O'Bryan-Tear CG, Shan M, Bruland ØS, Parker C (2014)
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
Lancet Oncol, 15 (7), 738-46
DOI 10.1016/S1470-2045(14)70183-4, PubMed 24836273

Schover LR, van der Kaaij M, van Dorst E, Creutzberg C, Huyghe E, Kiserud CE (2014)
Sexual dysfunction and infertility as late effects of cancer treatment
EJC Suppl, 12 (1), 41-53
DOI 10.1016/j.ejcsup.2014.03.004, PubMed 26217165

Solheim O, Gershenson DM, Tropé CG, Rokkones E, Sun CC, Weedon-Fekjaer H, Fosså SD (2014)
Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010)
Eur J Cancer, 50 (11), 1942-50
DOI 10.1016/j.ejca.2014.03.288, PubMed 24857045

Solheim O, Tropé CG, Rokkones E, Kærn J, Paulsen T, Salvesen HB, Hagen B, Vereide AB, Fosså SD (2014)
Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era"
Gynecol Oncol, 136 (2), 224-9
DOI 10.1016/j.ygyno.2014.12.010, PubMed 25511159

Sprauten M, Brydøy M, Haugnes HS, Cvancarova M, Bjøro T, Bjerner J, Fosså SD, Oldenburg J (2014)
Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors
J Clin Oncol, 32 (6), 571-8
DOI 10.1200/JCO.2013.51.2715, PubMed 24419125

Sternberg CN, Skoneczna I, Kerst JM, Albers P, Fossa SD, Agerbaek M, Dumez H, de Santis M, Théodore C, Leahy MG, Chester JD, Verbaeys A, Daugaard G, Wood L, Witjes JA, de Wit R, Geoffrois L, Sengelov L, Thalmann G, Charpentier D, Rolland F, Mignot L, Sundar S, Symonds P, Graham J et al. (2014)
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
Lancet Oncol, 16 (1), 76-86
DOI 10.1016/S1470-2045(14)71160-X, PubMed 25498218

Storås AH, Sanda MG, Ferrer M, Loge JH, Dahl AA, Steinsvik EA, Guedea F, Cvancarova M, Fosså SD (2014)
Localized prostate cancer in Norway, the United States, and Spain: between-country differences of variables before treatment among patients eligible for curative treatment
Clin Genitourin Cancer, 12 (4), e117-25
DOI 10.1016/j.clgc.2013.12.007, PubMed 24524968

van Rhee F, Wong RS, Munshi N, Rossi JF, Ke XY, Fosså A, Simpson D, Capra M, Liu T, Hsieh RK, Goh YT, Zhu J, Cho SG, Ren H, Cavet J, Bandekar R, Rothman M, Puchalski TA, Reddy M, van de Velde H, Vermeulen J, Casper C (2014)
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
Lancet Oncol, 15 (9), 966-74
DOI 10.1016/S1470-2045(14)70319-5, PubMed 25042199

0.12s